Chatrin Chatrin
Impact in
-
- Calcium signaling and nucleotide metabolism
-
- PARP inhibition in cancer therapy
Papers in
- Oncology 5
- PARP inhibition in cancer therapy 5
-
- Ubiquitin and proteasome pathways 9
- Protein Structure and Dynamics 1
- RNA modifications and cancer 1
- RNA regulation and disease 1
- Co-authors
- Syed Feroj Ahmed (3 shared papers)Lori Buetow (3 shared papers)Danny T. C. Huang (3 shared papers)Kang Zhu (8 shared papers)Ivan Ahel (10 shared papers)Gary J Sibbet (2 shared papers)Mads Gabrielsen (2 shared papers)Dragana Ahel (7 shared papers)
- Journals
- Science Advances (3 papers)Nucleic Acids Research (3 papers)The EMBO Journal (2 papers)Nature Communications (1 paper)Oncotarget (1 paper)
- Partner nations
- United KingdomFranceNorway
In The Last Decade
Chatrin Chatrin
14 papers receiving 374 citations
Peers
Comparison fields: 5 of 36
- Physiology 16
- Oncology 90
- Molecular Biology 254
- Geriatrics and Gerontology 13
- Immunology 43
Countries citing papers authored by Chatrin Chatrin
This map shows the geographic impact of Chatrin Chatrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chatrin Chatrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chatrin Chatrin more than expected).
Fields of papers citing papers by Chatrin Chatrin
This network shows the impact of papers produced by Chatrin Chatrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chatrin Chatrin. The network helps show where Chatrin Chatrin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chatrin Chatrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 73 | |
| 2 | 2020 | 59 | |
| 3 | 2023 | 51 | |
| 4 | 2023 | 45 | |
| 5 | 2024 | 36 | |
| 6 | 2023 | 34 | |
| 7 | 2024 | 20 | |
| 8 | 2024 | 18 | |
| 9 | 2025 | 16 | |
| 10 | 2017 | 12 | |
| 11 | 2025 | 6 | |
| 12 | 2025 | 3 | |
| 13 | 2025 | 2 | |
| 14 | 2026 | 1 | |
| 15 | 2026 | 0 |
About Chatrin Chatrin
Chatrin Chatrin is a scholar working on Oncology, Molecular Biology, Immunology, Public Health, Environmental and Occupational Health and Materials Chemistry, having authored 15 papers that have together received 376 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (9 papers), PARP inhibition in cancer therapy (5 papers), interferon and immune responses (2 papers), Protein Structure and Dynamics (1 paper), Mosquito-borne diseases and control (1 paper), Enzyme Structure and Function (1 paper), RNA modifications and cancer (1 paper) and RNA regulation and disease (1 paper). The work is most often cited by research in Physiology (16 citations), Oncology (90 citations), Molecular Biology (254 citations), Geriatrics and Gerontology (13 citations) and Immunology (43 citations). Chatrin Chatrin has collaborated with scholars based in United Kingdom, France and Norway. Frequent co-authors include Syed Feroj Ahmed, Lori Buetow, Danny T. C. Huang, Kang Zhu, Ivan Ahel, Gary J Sibbet, Mads Gabrielsen, Dragana Ahel, Brian O. Smith and Marcin J. Suskiewicz. Their work appears in journals such as Science Advances, Nucleic Acids Research, The EMBO Journal, Nature Communications and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.